MedTrace Logo

Effect of CES on Parasympathetic Tone

NCT02163967 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-10-11

Study results available
· View outcomes & findings →

Summary

The hypothesis is that CES stimulation will dose dependently increase parasympathetic tone. Healthy subjects will have three 20 minute sessions of CES stimulation, at three different intensities of stimulation, with each session occurring on a separate day. Effect on parasympathetic tone will determined by measuring high frequency heart rate variability before, during and after the stimulation. The Fisher Wallace Stimulator (FW100) which delivers a low dose alternating current a varying frequencies will be used for the stimulation.

Conditions

  • Autonomic Nervous System Imbalance

Interventions

DEVICE

Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100)

low voltage alternating current transcranial electrical stimulation

Sponsors & Collaborators

  • Fisher Wallace Laboratories

    collaborator INDUSTRY

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Margaret Altemus, MD · Weill Medical College, Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-11
Primary Completion
2013-03-15
Completion
2013-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163967 on ClinicalTrials.gov